24-week ashwagandha trial finds no liver or kidney harm
A 1,200-person multicentre trial published in Frontiers in Medicine finds 24 weeks of ashwagandha well-tolerated with no liver or kidney injury.
Simple explainers on world affairs, science, health and more.
All news under one minute
A 1,200-person multicentre trial published in Frontiers in Medicine finds 24 weeks of ashwagandha well-tolerated with no liver or kidney injury.
Zydus Lifesciences said the US Food and Drug Administration has concluded an inspection of its SEZ II manufacturing facility in Ahmedabad with…
DRC's Ebola outbreak passed 8,067 cases as violence at the Kigonze displacement camp threatens the response.
Ahead of World Heart Day, doctors urged women to prioritise heart health and warned smoking and second-hand smoke raise women's risk.
Pennsylvania's measles outbreak has grown to about 890 cases across 39 counties, with 55 new infections reported on September 28.
The FDA and CDC are investigating an E. coli O26:H11 outbreak linked to raw-milk cheese from Sierra Nevada Graziers in California.
A US study of 2,031 children aged 10-17 found 16.8% developed nutritional deficiencies within a year of starting GLP-1 drugs, but did…
Union Minister Mansukh Mandaviya said ESIC health security now covers 25 crore people, speaking at a CII-EFI labour conference in New Delhi…
The Health Ministry shifted AIIMS Jodhpur's executive director to Delhi and gave AIIMS Jammu's chief extra charge, ending the resident doctors' strike.
Thailand eliminated rubella as a public-health problem, WHO verified on Sept 5 — the seventh South-East Asian country to do so. Measles…